Dr. Anton Kraxner is a drug developer and clinical biomarker expert with over 15 years of experience in the biotech and pharmaceutical sectors, focusing on phase 1 and 2 clinical studies in oncology and metabolic diseases. They held postdoctoral researcher positions at Institut Pasteur and Ludwig-Maximilians Universität München, where they conducted significant research in viral immunity and dendritic cell signaling. Dr. Kraxner also served as a Senior Scientist at MorphoSys AG, leading the design and implementation of biomarker strategies for hemato-oncology. Currently, they continue to leverage their extensive expertise in drug discovery and development, contributing to advancements in clinical research and biomarker strategies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices